Addus HomeCare Co. (NASDAQ:ADUS) Short Interest Up 42.4% in June

Addus HomeCare Co. (NASDAQ:ADUS) saw a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 419,600 shares, an increase of 42.4% from the June 15th total of 294,700 shares. Based on an average daily volume of 154,500 shares, the short-interest ratio is presently 2.7 days.

Addus HomeCare Trading Up 0.9 %

Addus HomeCare stock opened at $120.90 on Friday. Addus HomeCare has a 12 month low of $78.35 and a 12 month high of $121.42. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.14. The business’s fifty day simple moving average is $114.21 and its two-hundred day simple moving average is $101.48. The company has a market capitalization of $2.19 billion, a price-to-earnings ratio of 30.00, a price-to-earnings-growth ratio of 2.29 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24. The company had revenue of $280.70 million for the quarter, compared to analysts’ expectations of $279.49 million. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. Addus HomeCare’s revenue was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.84 EPS. As a group, equities analysts predict that Addus HomeCare will post 4.36 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. StockNews.com cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Barclays lowered Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 target price for the company. in a research report on Tuesday, April 23rd. Oppenheimer lifted their price target on Addus HomeCare from $118.00 to $130.00 and gave the company an “outperform” rating in a research report on Friday, June 7th. TD Cowen increased their price objective on Addus HomeCare from $119.00 to $128.00 and gave the stock a “buy” rating in a report on Tuesday, June 18th. Finally, Bank of America raised their price objective on Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a research report on Tuesday, May 7th. One analyst has rated the stock with a sell rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $116.25.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 217 shares of the stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $116.13, for a total value of $25,200.21. Following the completion of the sale, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,186,500.21. The transaction was disclosed in a document filed with the SEC, which is available at this link. 4.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Addus HomeCare

A number of institutional investors have recently made changes to their positions in the company. Principal Securities Inc. purchased a new position in Addus HomeCare in the 4th quarter worth approximately $26,000. GAMMA Investing LLC bought a new stake in shares of Addus HomeCare in the 4th quarter worth $34,000. EntryPoint Capital LLC purchased a new position in shares of Addus HomeCare in the first quarter worth $44,000. Assetmark Inc. lifted its holdings in shares of Addus HomeCare by 33.3% during the fourth quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock valued at $165,000 after purchasing an additional 443 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. bought a new position in shares of Addus HomeCare during the fourth quarter valued at $214,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.